417 related articles for article (PubMed ID: 33304809)
1. Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD).
Ataya A
Respir Med Case Rep; 2020; 31():101309. PubMed ID: 33304809
[TBL] [Abstract][Full Text] [Related]
2. Treatment of lung disease in alpha-1 antitrypsin deficiency: a systematic review.
Edgar RG; Patel M; Bayliss S; Crossley D; Sapey E; Turner AM
Int J Chron Obstruct Pulmon Dis; 2017; 12():1295-1308. PubMed ID: 28496314
[TBL] [Abstract][Full Text] [Related]
3. Lung and liver transplantation in patients with alpha-1 antitrypsin deficiency.
Zamora MR; Ataya A
Ther Adv Chronic Dis; 2021; 12_suppl():20406223211002988. PubMed ID: 34408830
[TBL] [Abstract][Full Text] [Related]
4. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
5. Immune activation in α1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm.
Baraldo S; Turato G; Lunardi F; Bazzan E; Schiavon M; Ferrarotti I; Molena B; Cazzuffi R; Damin M; Balestro E; Luisetti M; Rea F; Calabrese F; Cosio MG; Saetta M
Am J Respir Crit Care Med; 2015 Feb; 191(4):402-9. PubMed ID: 25412116
[TBL] [Abstract][Full Text] [Related]
6. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
Lascano JE; Campos MA
Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
[TBL] [Abstract][Full Text] [Related]
7. The natural history of lung function after lung transplantation for α(1)-antitrypsin deficiency.
Banga A; Gildea T; Rajeswaran J; Rokadia H; Blackstone EH; Stoller JK
Am J Respir Crit Care Med; 2014 Aug; 190(3):274-81. PubMed ID: 25003824
[TBL] [Abstract][Full Text] [Related]
8. Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease.
Serban KA; Pratte KA; Strange C; Sandhaus RA; Turner AM; Beiko T; Spittle DA; Maier L; Hamzeh N; Silverman EK; Hobbs BD; Hersh CP; DeMeo DL; Cho MH; Bowler RP
EBioMedicine; 2022 Oct; 84():104262. PubMed ID: 36155958
[TBL] [Abstract][Full Text] [Related]
9. Bronchoscopic Lung Volume Reduction in Patients with Emphysema due to Alpha-1 Antitrypsin Deficiency.
Everaerts S; Hartman JE; Van Dijk M; Koster TD; Slebos DJ; Klooster K
Respiration; 2023; 102(2):134-142. PubMed ID: 36549279
[TBL] [Abstract][Full Text] [Related]
10. α
Bazzan E; Tinè M; Biondini D; Benetti R; Baraldo S; Turato G; Fagiuoli S; Sonzogni A; Rigobello C; Rea F; Calabrese F; Foschino-Barbaro MP; Miranda E; Lomas DA; Saetta M; Cosio MG
Chest; 2018 Sep; 154(3):607-616. PubMed ID: 29763589
[TBL] [Abstract][Full Text] [Related]
11. Surgery for patients with Alpha 1 Antitrypsin Deficiency: A review.
Zamora M
Am J Surg; 2019 Sep; 218(3):639-647. PubMed ID: 30360894
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of Alpha-1 Antitrypsin Lung Disease.
Kalfopoulos M; Wetmore K; ElMallah MK
Methods Mol Biol; 2017; 1639():9-19. PubMed ID: 28752442
[TBL] [Abstract][Full Text] [Related]
13. The spectrum of clinical sequelae associated with alpha-1 antitrypsin deficiency.
Tejwani V; Stoller JK
Ther Adv Chronic Dis; 2021; 12_suppl():2040622321995691. PubMed ID: 34408829
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentations of four patients with rare Alpha 1 Antitrypsin variants identified in a single US center.
Kueppers F
Respir Med Case Rep; 2021; 32():101345. PubMed ID: 33552892
[TBL] [Abstract][Full Text] [Related]
15. Similarities in the Computed Tomography Appearance in α1-Antitrypsin Deficiency and Smoking-Related Chronic Obstructive Pulmonary Disease in a Smoking Collective.
Konietzke P; Jobst B; Wagner WL; Jarosch I; Graber R; Kenn K; Kauczor HU; Wielpütz MO
Respiration; 2018; 96(3):231-239. PubMed ID: 29940576
[TBL] [Abstract][Full Text] [Related]
16. Imaging in alpha-1 antitrypsin deficiency: a window into the disease.
Huang YT; Wencker M; Driehuys B
Ther Adv Chronic Dis; 2021; 12_suppl():20406223211024523. PubMed ID: 34408834
[TBL] [Abstract][Full Text] [Related]
17. PiSZ alpha-1 antitrypsin deficiency (AATD): pulmonary phenotype and prognosis relative to PiZZ AATD and PiMM COPD.
Green CE; Vayalapra S; Hampson JA; Mukherjee D; Stockley RA; Turner AM
Thorax; 2015 Oct; 70(10):939-45. PubMed ID: 26141072
[TBL] [Abstract][Full Text] [Related]
18. Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.
Casas F; Blanco I; Martínez MT; Bustamante A; Miravitlles M; Cadenas S; Hernández JM; Lázaro L; Rodríguez E; Rodríguez-Frías F; Torres M; Lara B
Arch Bronconeumol; 2015 Apr; 51(4):185-92. PubMed ID: 25027067
[TBL] [Abstract][Full Text] [Related]
19. Emphysema: looking beyond alpha-1 antitrypsin deficiency.
Janssen R; Piscaer I; Franssen FME; Wouters EFM
Expert Rev Respir Med; 2019 Apr; 13(4):381-397. PubMed ID: 30761929
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
